142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

314585
How Science Informs FDA Regulatory Decisions

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 4:50 PM - 5:10 PM

RADM David Ashley, PhD , Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD
This session will help the public health community understand how science is used to make the most effective regulatory decisions. At the conclusion of this session, attendees will have an understanding of CTPs scientific priorities and the role science plays in informing the regulatory process.

Learning Areas:

Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Describe how the CTP Office of Science supports and evaluates research to ensure that CTP has the science base to make regulatory decisions.

Keyword(s): Public Health Policy

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the director of the Office of Science at the Food and Drug Administration’s Center for Tobacco Products, which is responsible for developing and assuring that the science related to the morbidity and mortality of tobacco products results in regulatory decisions that have the greatest impact on public health. I have performed extensive research on cigarette design and use and their effect on emissions. I have also studied the resulting biomarkers of exposure.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.